BBH

VanEck Vectors Biotech ETF

Up$129.21
+$1.53
(+1.2%)
As of 1:00:00 AM EDT | 2/15/19  |  Market Closed

BBH Trading Data

Open

$128.11

Low Price

$128.11

High Price

$129.26

Previous Last Price

$127.68

Bid Size

$0 X 0

Ask Size

$0 X 0

BBH Portfolio Data

AUM

$412,467,800

Shares

3,247

PE Ratio

25.69

Price / Book Ratio

3.73

Expense Ratio

0.35

Net Asset Value

$127.05

Volume

Volume

7,400

Avg. Volume (YDT)

18,447

Dollar Volume

$698,320

Weekly Avg. Volume

7,300

Monthly Avg. Volume

16,350

Quarterly Avg. Volume

28,038

BBH Fund Description

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. Expenses for BBH are capped contractually at 0.35% until at least February 1, 2018. Cap excludes certain expenses, such as interest.

BBH Chart

BBH Summary

Fund Family

Van Eck Associates

Tracks This Index

VanEck Vectors Biotech ETF

Inception Date

2011-12-21

Asset Class

Equity

Asset Class Size

Biotech

BBH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

BBH Holdings

Top 10 Holdings

Amgen Inc (AMGN)
8.03%
Celgene Corp (CELG)
6.35%
Gilead Sciences Inc (GILD)
6.28%
Incyte Corp (INCY)
5.51%
Exact Sciences Corp (EXAS)
5.48%
Regeneron Pharmaceuticals Inc (REGN)
5.45%
Vertex Pharmaceuticals Inc (VRTX)
5.25%
Iqvia Holdings Inc (IQV)
5.15%
Biogen Inc (BIIB)
5%
Alexion Pharmaceuticals Inc (ALXN)
4.81%

Total BBH Holdings

Total Holdings: 26

Amgen Inc (AMGN)
8.03%
Celgene Corp (CELG)
6.35%
Gilead Sciences Inc (GILD)
6.28%
Incyte Corp (INCY)
5.51%
Exact Sciences Corp (EXAS)
5.48%
Regeneron Pharmaceuticals Inc (REGN)
5.45%
Vertex Pharmaceuticals Inc (VRTX)
5.25%
Iqvia Holdings Inc (IQV)
5.15%
Biogen Inc (BIIB)
5%
Alexion Pharmaceuticals Inc (ALXN)
4.81%
Allergan Plc (AGN)
4.52%
Biomarin Pharmaceutical Inc (BMRN)
4.42%
Illumina Inc (ILMN)
4.31%
Qiagen Nv (QGEN)
4.24%
Sarepta Therapeutics Inc (SRPT)
4.15%
Charles River Laboratories Internationa (CRL)
3.47%
Grifols Sa (GRFS)
2.76%
Neurocrine Biosciences Inc (NBIX)
2.53%
United Therapeutics Corp (UTHR)
2.4%
Alnylam Pharmaceuticals Inc (ALNY)
2.39%
Nektar Therapeutics (NKTR)
2.29%
Ionis Pharmaceuticals Inc (IONS)
1.94%
Seattle Genetics Inc (SGEN)
1.77%
Bluebird Bio Inc (BLUE)
1.66%
Market Vectors Biotech ETF (BBH)
0%
0%

BBH Technicals

Alpha

-9.89

Beta

1.17

Leverage

Long

Standard Deviation

7.09

BBH Dividends

Dividend Date

2018-12-20

Latest Dividend

5.551

Annual Dividend

5.55

Annual Dividend Rate

5.55

Annual Dividend Yield

4.37

BBH Performance

YTD Return

16.7%

1 Year Return

3.19%

3 Year Return

26.5%

5 Year Return

23.33%

10 Year Return

136.85%

BBH Related Articles